Study compares hospitalized infection risk for biologics in RA
(HealthDay)—For patients with rheumatoid arthritis (RA) with prior biologic exposure, the risk of hospitalized infection is increased with etanercept, infliximab, and rituximab versus abatacept, accor
Updated on: April 08,2024
16

Study compares hospitalized infection risk for biologics in RA
(HealthDay)—For patients with rheumatoid arthritis (RA) with prior biologic exposure, the risk of hospitalized infection is increased with etanercept, infliximab, and rituximab versus abatacept, accor
Updated on:April 08,2024
16
